This fifth annual meeting of the medtech and pharma sectors will look at how the two industries are developing increasingly convergent technologies to both detect and diagnose, as well as to treat disease. Not only are more and more drugs being approved with companion diagnostics in order to reach the right group of patients, but the diagnostics themselves have become increasingly important in disease prevention. This conference is aimed at experts and professionals from the medtech and pharma industries as well as the regulatory community.
